Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma.
about
Creation of an engineered APC system to explore and optimize the presentation of immunodominant peptides of major allergensCellular immunotherapy for malignant gliomas.Perspectives on investigational drugs and immunotherapies for glioblastoma.Agonist OX40 immunotherapy improves survival in glioma-bearing mice and is complementary with vaccination with irradiated GM-CSF-expressing tumor cells.Synergy of vaccination and agonist OX40 treatment-toward a mechanism-driven combination of glioma immunotherapy.
P2860
Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vaccination with Irradiated Au ...... th Recurrent Malignant Glioma.
@en
Vaccination with Irradiated Au ...... th Recurrent Malignant Glioma.
@nl
type
label
Vaccination with Irradiated Au ...... th Recurrent Malignant Glioma.
@en
Vaccination with Irradiated Au ...... th Recurrent Malignant Glioma.
@nl
prefLabel
Vaccination with Irradiated Au ...... th Recurrent Malignant Glioma.
@en
Vaccination with Irradiated Au ...... th Recurrent Malignant Glioma.
@nl
P2093
P2860
P1476
Vaccination with Irradiated Au ...... th Recurrent Malignant Glioma.
@en
P2093
Alexandra J Golby
Elizabeth R Gerstner
Glenn Dranoff
Martin C Mihm
Pamela S Jones
Pankaj Agarwalla
Patrick Y Wen
Ramana Gorrepati
Tetsuro Sasada
Tracy T Batchelor
P2860
P304
P356
10.1158/1078-0432.CCR-15-2163
P407
P577
2016-02-12T00:00:00Z